Summary
Despite advances for the treatment of cancer, the prognosis for patients suffering from malignant brain tumors remains dismal. High-grade neoplasms, such as gliomas, are highly invasive and spawn widely disseminated microsatellites that have limited the efficacy of surgical and adjunctive therapies. The cancer stem cell hypothesis suggests that conventional chemotherapeutic treatments kill differentiated and differentiating cells which often form the bulk of the tumor. One major concern is that the cells which give rise to the tumor, the cancer stem cells, remain untouched and may be responsible for a relapse of the disease. Therefore, an adjunctive therapy to current cancer treatment is critical for the survivability of patients suffering from brain tumors. We have successfully engineered tumor-tropic neural stem cells to deliver antineoplastic gene products directly to the tumor-producing cells. This potential therapeutic strategy may safely eradicate tumor-producing cells in the brain while minimizing damage to normal, healthy cells.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Snyder, EY., Deichter, DL., Walsh, C., Arnold-Aldea, S., Hartweig, EA., and Cepko, CL. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell, 68: 33–51, 1992.
Yip, S., Aboody, KS., Burns, M., Imitola, J., Boockvar, JA., Allport, J., Park, KI., Teng, YD., Lachyankar, M., McIntosh, T., O’Rourke, DM., Khoury, S., Weissleder, R., Black, PM., Weiss, W., and Snyder, EY. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J., 9: 189–204, 2003.
Aboody, KS., Brown, A., Rainov, NG., Bower, KA., Liu, S., Yang, W., Small, JE., Herrlinger, U., Ourednik, V., Black, PM., Breakefield, XO., and Snyder, EY. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA., 97: 12846–12851, 2000.
Elzaouk, L., Moelling, K., and Pavlovic, J. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp. Dermatology, 15: 865–874, 2006.
Song, K., Benhaga N., Anderson, RL., and Khosravi-Far, R. Transduction of tumor-necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res., 66(12): 6304–6311, 2006.
Kim, SK., Kim, SU., Park, IH., Bang, JH., Aboody, KS., Wang, KC., Cho, BK., Kim, M., Menon, LG., Black, PM., and Carroll, RS. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res., 12(18): 5550–5556, 2006.
Aboody, KS., Najbauer, J., Schmidt, NO., Yang, W., Wu, JK., Zhuge, Y., Przylecki, W., Carroll, R., Black, PM., and Perides, G. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro-Oncol., 8(2): 119–126, 2005.
Ehtesham, M., Kabos, P., Kabosova, A., Neuman, T., Black, KL., and Yu, JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res., 62(20): 5657–5663, 2002.
Yang, YS., Hiu, L. and Zhang, JN. Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol., 23(6): 381–389, 2004.
Ehtesham, M., Kabos, P., Guitierrez, MA., Chung, NH., Griffith, TS., Black, KL., and Yu, JS. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res., 62(24): 7170–7174, 2002.
Logan, AC., Haas, DL., Kafri, T., and Kohn, DB. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J. Virol., 78: 8421–8436, 2004.
Logan, AC., Nightingale, SJ., Haas, DL., Cho, GJ., Pepper, KA., and Kohn, DB. Factors influencing the titer and infectivity of lentiviral vectors. Hum. Gene Ther., 15: 976–988, 2004.
Miyoshi, H., Smith, KA., Mosier, DE., Verma, IM., and Torbett, BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science, 283: 682–686, 1999.
Logan, AC., Lutzko, C., and Kohn, DB. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol., 13: 429–436, 2002.
Van Damme, A., Thorrez, L., Ma, L., Vandenburgh, H., Eyckmans, J., Dell’Accio, F., De Bari, C., Luyten, F., Lillicrap, D., Collen, D., VandenDriessche, T., and Chuah, MK. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells, 24: 896–907, 2006.
Schorpp, M., Jager, R., Schellander, K., Schenkel, J., Wagner, EF., Weiher, H., and Angel, P. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res., 24: 1787–1788, 1996.
Torbett, BE. Reporter genes: too much of a good thing? J. Gene Med., 4: 478–479, 2002.
Acknowledgments
This work was supported by a Susan G. Komen Breast Cancer Foundation grant PDF0403205 and a CBCRP grant12IB-0122 to B. Felding-Habermann in consortium with EY Snyder.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Katz, J., Krueger, J., Felding-Habermann, B., Snyder, E.Y. (2009). Maintaining and Engineering Neural Stem Cells for Delivery of Genetically Encoded Therapy to Brain Tumors. In: Yu, J. (eds) Cancer Stem Cells. Methods in Molecular Biology, vol 568. Humana Press. https://doi.org/10.1007/978-1-59745-280-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-59745-280-9_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-938-3
Online ISBN: 978-1-59745-280-9
eBook Packages: Springer Protocols